The maker of OxyContin, one of the most common prescription painkillers involved in opioid overdose deaths, will no longer market the drug to doctors, an announcement that came Saturday as Purdue Pharma faces a lawsuit for deceptive marketing brought by cities and counties across the U.S., including several in Maine. The days of marketing opioids to U.S. doctors are over, according to a statement issued by Purdue Pharma. The drug manufacturer has also cut its sales force by more than half. Just